Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

Alkermes announces plans to advance ALKS 5461 phase 3 program for major depressive disorder

Alkermes plc today announced that it has successfully completed its End-of-Phase 2 interactions with the U.S. Food and Drug Administration (FDA), and the company plans to advance ALKS 5461 into phase 3 development in early 2014.

9 Oct 2013

DSP to set up anti-cancer drugs sales company in US

Dainippon Sumitomo Pharma Co., Ltd. (DSP) announced on October 9 that it has decided to establish an anti-cancer drugs sales company in the United States as a wholly-owned subsidiary of DSP's 100% owned U.S. holding company.

9 Oct 2013

BUSM researchers develop screening tool to detect intimate partner violence in females

Boston University School of Medicine (BUSM) researchers have identified a promising screening tool to detect intimate partner violence (IPV) in females in the VA Boston Healthcare System.

9 Oct 2013

Binge eating disorder is different from anorexia nervosa and bulimia nervosa

Food addiction is not yet recognised as a mental disorder but certain obese individuals clearly display addictive-like behaviour towards food.

9 Oct 2013

UCLA investigates high rates of schizophrenia in people with 22q11.2 deletion syndrome

UCLA has joined an international consortium to investigate the high rates of schizophrenia and other neuropsychiatric disorders in those who are affected with Chromosome 22q11.2 deletion syndrome, a disorder caused by the deletion of a small piece of chromosome number 22.

9 Oct 2013

Two gene mutations associated with increased risk of developing eating disorders

Eating disorders like anorexia nervosa and bulimia often run in families, but identifying specific genes that increase a person's risk for these complex disorders has proved difficult.

9 Oct 2013

Bipolar disorder ‘distinct’ from borderline personality disorder

Researchers say that there are clear clinical differences between depressed patients with bipolar II disorder and those with borderline personality disorder, which supports the two being treated as distinct conditions.

8 Oct 2013

Brain & Behavior Research Foundation to hold research symposium on mental health

The Brain & Behavior Research Foundation, an organization dedicated to improving the lives of those with mental illness through the transformative power of neuroscience and psychiatric research, will hold its 25th Annual Mental Health Research Symposium on Friday, October 25th from 9:00 am to 4:30 p.m. at the Kaufman Music Center, located at 129 W. 67th St. in New York City.

8 Oct 2013

Only small proportion of adults receive formal diagnosis, treatment for ADHD

Up to two-thirds of children with attention deficit/hyperactivity disorder find their disorder persists into adulthood yet only a small proportion of adults ever receive a formal diagnosis and treatment, research suggests.

8 Oct 2013

Study: Effect of medication treatments on patients with alcoholism and anxiety

Domenic Ciraulo, MD, chair of psychiatry at Boston University School of Medicine (BUSM) and David H. Barlow, PhD, professor of psychology at Boston University (BU), have collaborated to study the effect of behavioral and medication treatments on patients with alcoholism and anxiety.

8 Oct 2013

NAC amino acid may offer new treatment options for psychiatric disorders

Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is an amino acid, N-Acetyl Cysteine (NAC), which appears to reduce the core symptoms of bipolar disorder, schizophrenia, depression, autism and cravings in addictions including cocaine, cannabis abuse and cigarette smoking.

8 Oct 2013

Babies born to moms who smoked when pregnant have increased risk of nicotine addiction in adulthood

Adult women whose mothers had increased levels of stress hormones while they were pregnant are at greater risk of becoming addicted to nicotine, according to a new study led by a Miriam Hospital researcher.

8 Oct 2013

Brain & Behavior Research Foundation to honor 7 scientists for exceptional research on mental health

The Brain & Behavior Research Foundation celebrates the transformative power of neuroscience and psychiatric research to improve the lives of those with mental illness. Seven exceptional scientists will be honored at the Annual National Awards Dinner at the Pierre Hotel in New York City on Friday, October 25, 2013.

7 Oct 2013

Glutamergic agents may be used as novel treatment for mood and anxiety disorders

Glutamergic agents may one day be used as a novel treatment for mood and anxiety disorders, new research presented at the 26th ECNP Congress suggests.

7 Oct 2013

Individuals diagnosed with ASD more likely to have gene deletions, shows analysis

Using powerful genetic sequencing technology, a team of investigators, led by researchers at the Icahn School of Medicine at Mount Sinai, scanned the genome of hundreds of individuals, and discovered those diagnosed with autism spectrum disorder (ASD) were more likely to have gene deletions than were people without the disorder.

4 Oct 2013

Comorbid anxiety warns of bipolar psychotherapy need

Comorbid anxiety may flag those patients with bipolar depression who are in particular need of intensive psychotherapy, suggest findings from the Systematic Treatment Enhancement Program for Bipolar Disorder.

3 Oct 2013

Affective dimensions aid bipolar disorder diagnosis

Measuring affective dimensions can help clinicians diagnose bipolar disorder in patients with first-episode psychosis, researchers report.

3 Oct 2013

Study: One in three teens with bipolar disorder develop substance abuse

A study published in the October 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that approximately one in three teens with bipolar disorder developed substance abuse, for the first time, during 4 years of follow-up.

3 Oct 2013

Maternal smoking during pregnancy associated with twofold increased risk of BD in offspring

A study published today in the American Journal of Psychiatry suggests an association between smoking during pregnancy and increased risk for developing bipolar disorder in adult children.

2 Oct 2013

Sun Pharma, Intrexon partner to develop controllable gene-based therapies for ocular diseases

Sun Pharmaceutical Industries Ltd., an international specialty pharmaceutical company focused on chronic diseases, through its subsidiary, and Intrexon Corporation, a leader in synthetic biology, today announced the formation of a joint venture to develop controllable gene-based therapies for the treatment of ocular diseases that cause partial or total blindness in millions of people worldwide.

1 Oct 2013

Psychiatry News and Research

Further Reading

Alkermes announces plans to advance ALKS 5461 phase 3 program for major depressive disorder

DSP to set up anti-cancer drugs sales company in US

BUSM researchers develop screening tool to detect intimate partner violence in females

Binge eating disorder is different from anorexia nervosa and bulimia nervosa

UCLA investigates high rates of schizophrenia in people with 22q11.2 deletion syndrome

Two gene mutations associated with increased risk of developing eating disorders

Bipolar disorder ‘distinct’ from borderline personality disorder

Brain & Behavior Research Foundation to hold research symposium on mental health

Only small proportion of adults receive formal diagnosis, treatment for ADHD

Study: Effect of medication treatments on patients with alcoholism and anxiety

NAC amino acid may offer new treatment options for psychiatric disorders

Babies born to moms who smoked when pregnant have increased risk of nicotine addiction in adulthood

Brain & Behavior Research Foundation to honor 7 scientists for exceptional research on mental health

Glutamergic agents may be used as novel treatment for mood and anxiety disorders

Individuals diagnosed with ASD more likely to have gene deletions, shows analysis

Comorbid anxiety warns of bipolar psychotherapy need

Affective dimensions aid bipolar disorder diagnosis

Study: One in three teens with bipolar disorder develop substance abuse

Maternal smoking during pregnancy associated with twofold increased risk of BD in offspring

Sun Pharma, Intrexon partner to develop controllable gene-based therapies for ocular diseases

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News